Behrad Derakhshan

Insider Reports History

Location
Boulder, CO
Signature
/s/ John R Moore Attorney-in-Fact for Behrad Derakhshan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Behrad Derakhshan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Business Officer Restricted Stock Units 30,000 $437,294 $18.91 12 Aug 2025 Direct
Edgewise Therapeutics, Inc. Chief Business Officer Common Stock 23,645 $316,663 $13.39 12 Aug 2025 Direct
Edgewise Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 180,000 12 Aug 2025 Direct

Insider Reports Filed by Behrad Derakhshan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EWTX Edgewise Therapeutics, Inc. 12 Aug 2025 5 -$33,360 4 Chief Business Officer 14 Aug 2025, 19:43
EWTX Edgewise Therapeutics, Inc. 01 May 2025 3 -$27,824 4 Chief Business Officer 07 May 2025, 21:09
EWTX Edgewise Therapeutics, Inc. 05 Feb 2025 3 -$281,000 4 Chief Business Officer 07 Feb 2025, 16:37
EWTX Edgewise Therapeutics, Inc. 20 Sep 2024 3 -$1,139,942 4 Chief Business Officer 24 Sep 2024, 20:24
EWTX Edgewise Therapeutics, Inc. 12 Aug 2024 2 $0 4 Chief Business Officer 14 Aug 2024, 16:14
EWTX Edgewise Therapeutics, Inc. 01 May 2024 3 -$32,487 4 Chief Business Officer 03 May 2024, 18:29
EWTX Edgewise Therapeutics, Inc. 07 Feb 2024 9 -$180,958 4 Chief Business Officer 09 Feb 2024, 17:42
EWTX Edgewise Therapeutics, Inc. 17 Aug 2023 1 $0 4 Chief Business Officer 18 Aug 2023, 19:13
EWTX Edgewise Therapeutics, Inc. 01 May 2023 3 -$15,557 4 Chief Business Officer 03 May 2023, 18:26
EWTX Edgewise Therapeutics, Inc. 08 Aug 2022 1 $0 4 Chief Business Officer 10 Aug 2022, 17:42
EWTX Edgewise Therapeutics, Inc. 01 May 2022 1 $0 4 Chief Business Officer 03 May 2022, 16:14
EWTX Edgewise Therapeutics, Inc. 17 Aug 2021 1 $0 4 Chief Business Officer 19 Aug 2021, 17:09